NaviFUS Corporation is a Biotech company dedicated to providing novel platform solutions for crossing the blood-brain barrier (BBB) for enhanced oncology drug delivery. The company’s main product, the NaviFUS System, is designed to utilize non-invasive ultrasound energy to enable transient and safe enhancement of BBB permeability to facilitate the transport of small or large molecular CNS drugs to target tumor tissue at high precision for better treatment outcomes. The company was established in 2015 and is headquartered in Taipei City, Taiwan.
Headquarters
12F., No.246, Sec 3, Chengde Rd., Datong Dist
Taipei City; Taipei City;
Contact Details: Purchase the NaviFUS Corporation report to view the information.
Website: http://navifus.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service